Z Squared (ZSQR) CMO Christopher Schadel Buys 1,000 Shares

What Happened Christopher Ryan Schadel, Chief Marketing Officer of Z Squared, reported an open-market purchase of 1,000 shares on August 18, 2026 at $3.92 per share ($3,920 total). The filing also discloses several awards/derivative grants earlier in 2026: a 100,000-share stock option (grant date April 27, 2026) and two restricted stock unit (RSU) grants — 9,868 RSUs (April 27, 2026) and 2,806 RSUs (June 3, 2026). The RSUs reflect supplemental and annual bonus awards with a combined grant-date fair value of roughly $180,000; the option is a performance-linked grant.

Key Details

• Purchase (P): 1,000 shares on 2026-08-18 at $3.92 each — total cash outlay $3,920.
• Awards (A):
  • 100,000-share stock option granted 2026-04-27 (exercise price = fair market value on grant date). Option vests only if fair market value rises 50% above grant-date value; exercisable up to 10 years.
  • 9,868 RSUs granted 2026-04-27 (annual bonus; ~$150,000 grant-date value).
  • 2,806 RSUs granted 2026-06-03 (supplemental award; ~$30,000 grant-date value).
• RSU vesting: RSUs vest in equal quarterly installments over one year beginning on their respective grant dates, subject to continued employment; each RSU converts to one share upon vesting and has no expiration.
• Derivative vs. direct ownership: The RSUs and option are contingent/derivative awards (no immediate shares received); only the 1,000-share open-market purchase added current shares.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: Report filed Aug 20, 2026 covering transactions through Aug 18, 2026 — no indication of a late filing in the provided data.
• No 10b5-1 plan, tax-withholding sale or gift notation in the disclosed footnotes.

Context

• The open-market purchase is a direct acquisition (cash purchase) and is often considered a stronger signal of an insider adding to holdings than awards, though motivations aren’t disclosed.
• The 100,000-share option is performance‑based (vests only if the stock increases 50% from the grant-date FMV), so it does not provide immediate exercisable shares and may only have value if the stock appreciates significantly.
• RSUs are typical compensation/bonus instruments; they will convert to common shares only as they vest over the coming year.